Steris (NYSE: STE) reported Q2 EPS of $0.68, $0.06 better than the analyst estimate of $0.62. Revenue for the quarter came in at $462.7 million versus the consensus estimate of $452.5 million.

Steris sees FY2015 EPS of $2.86-$2.91, versus the consensus of $2.87.

For earnings history and earnings-related data on Steris (STE) click here.